GREENVILLE, S.C. and SACRAMENTO, Calif., Jan. 6, 2026 /PRNewswire/ -- PAI Pharma ("PAI"), a portfolio company of Olympus Partners and a leading U.S. developer, manufacturer and marketer of oral liquid medicines, today announced the acquisition of Nivagen Pharmaceuticals, Inc. ("Nivagen"),...
Hence then, the article about pai pharma acquires nivagen pharmaceuticals expanding domestic sterile injectable manufacturing and expanding ready to use rtu product offering in the hospital market was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( PAI Pharma Acquires Nivagen Pharmaceuticals, Expanding Domestic Sterile Injectable Manufacturing and Expanding Ready-To-Use ("RTU") Product Offering in the Hospital Market )
Also on site :
- Amazon’s 'Buttery-Soft' $7 Long-Sleeve Shirt Is a 'Staple Piece' That Has Shoppers Running Back for More
- ‘We just need someone who’s not crazy’: Inside the White House decision to nominate Erica Schwartz as CDC director
- 'Salem's Finest' Is Back! Lani Grant Reunites With Her Family in Emotional New 'Days of Our Lives' Promo